These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts. Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T Clin Exp Immunol; 2007 Jul; 149(1):146-54. PubMed ID: 17459077 [TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation. Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509 [TBL] [Abstract][Full Text] [Related]
4. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611 [TBL] [Abstract][Full Text] [Related]
5. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis. Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384 [TBL] [Abstract][Full Text] [Related]
6. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T Clin Exp Immunol; 2005 Nov; 142(2):285-91. PubMed ID: 16232215 [TBL] [Abstract][Full Text] [Related]
7. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor. Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639 [TBL] [Abstract][Full Text] [Related]
8. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. Guo L; Cui ZM; Zhang J; Huang Y Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066 [TBL] [Abstract][Full Text] [Related]
9. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro. Hu W; Liu Y; Zhou W; Si L; Ren L PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301 [TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516 [TBL] [Abstract][Full Text] [Related]
11. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580 [TBL] [Abstract][Full Text] [Related]
12. The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro. Gruber HE; Marrero E; Ingram JA; Hoelscher GL; Hanley EN Biotech Histochem; 2017; 92(1):7-14. PubMed ID: 27869573 [TBL] [Abstract][Full Text] [Related]
13. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction. Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654 [TBL] [Abstract][Full Text] [Related]
14. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Deng L; Chen N; Li Y; Zheng H; Lei Q Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997 [TBL] [Abstract][Full Text] [Related]
15. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. Chandrasekar B; Bysani S; Mummidi S J Biol Chem; 2004 Jan; 279(5):3188-96. PubMed ID: 14625285 [TBL] [Abstract][Full Text] [Related]
16. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering. Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer. Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586 [TBL] [Abstract][Full Text] [Related]
18. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion. Koenen A; Babendreyer A; Schumacher J; Pasqualon T; Schwarz N; Seifert A; Deupi X; Ludwig A; Dreymueller D PLoS One; 2017; 12(3):e0173486. PubMed ID: 28267793 [TBL] [Abstract][Full Text] [Related]
19. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis. Isozaki T; Arbab AS; Haas CS; Amin MA; Arendt MD; Koch AE; Ruth JH Arthritis Rheum; 2013 Jul; 65(7):1736-46. PubMed ID: 23633118 [TBL] [Abstract][Full Text] [Related]
20. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Wang J; Lu Y; Wang J; Koch AE; Zhang J; Taichman RS Cancer Res; 2008 Dec; 68(24):10367-76. PubMed ID: 19074906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]